PressRoom

On going Projects table
Subjects Yungjin Pharm. Co., Ltd. applies for patent for the ¡°Limaprost¡± formulation technology hit 3701
Write Marketing Date 2012-01-18

3 May 2011

 

Yungjin Pharm. applied for patent for its new ¡°Limaprost¡± formulation technology.

 

¡°Limaprost¡± or ¡°Limaprost alfadex¡± is a derivative of prostaglandin E1 used to prevent or treat peripheral circulatory disturbance, but it is an unstable substance. Yungjin improved the problem of its vulnerability to moisture and made drug intake more convenient with most convenient drug intake.

 

Yungjin plans to release ¡°Opast tablet (Limaprost formulation)¡± in June and has the ambition to make it an annual sale of 10 million dollars product.  

Press Room List page move

Quick menu